A Randomised Trial of DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children: The DOMInO Trial

Phase 4

Completed

• Conditions: Pregnancy; Reproductive Health and Childbirth - Childbirth and postnatal care; Reproductive Health and Childbirth - Depression

• Registration Number: ACTRN12605000569606
• Lead Sponsor: H&MRC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-30
• Study Completion: 2009-12-16
• Last Update Posted: 21 June 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 2399

Inclusion Criteria

Singleton pregnancy of 18-21 weeks gestation; no known fetal abnormality; women with no documented history of alcohol or drug abuse; no participation in other clinical trials with fatty acid intervention.

Exclusion Criteria

Bleeding disorders where DHA rich tuna oil is contraindicated.

Study & Design

• Study Type: Interventional
• Study Design: Not specified